Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Meros Polymers

Meros Polymers?uq=x1rNslWr
2009 FOUNDED
PRIVATE STATUS
Angel LATEST DEAL TYPE (Cancelled)
$377K LATEST DEAL AMOUNT
5 INVESTORS
Description

Owner and opeartor of a company for the development of nano-micellar substance to solve the problem of drug solubility. The company is focused on the development of a polymer platform technology that can carry drugs to specific areas of the body and improve drug effectiveness.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1500 Manulife Place, 10180
  • 101 Street
  • Edmonton, Alberta T5J 4K1
  • Canada

+1 (780) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Meros Polymers’s full profile, request a free trial.

Meros Polymers Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 20-Nov-2015 $377K Cancelled Startup
3. Grant 01-Jan-2013 00000 Completed Startup
2. Accelerator/Incubator 01-Jan-2010 Completed Startup
1. Angel (individual) Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Meros Polymers Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Alberta Heritage Foundation for Medical Research Endowment Fund Limited Partner 000 0000 000000 0
Canadian Institutes of Health Research Corporation 000 0000 000000 0
Innotech Alberta VC-Backed Company 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
TEC Edmonton Accelerator/Incubator 000 0000 000000 0

Meros Polymers Executive Team (2)

Name Title Board
Seat
Contact
Info
Afsaneh Lavasanifar Ph.D Chief Scientific Officer, Co-Founder and Vice-President

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »